Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients

Background. The secondary infection of multi and extensively drug-resistant “Acinetobacter baumannii” in severely ill COVID-19 individuals is usually associated with extended hospitalisation and a high mortality rate. The current study aimed to assess the exact incidence rate of A. baumannii coinfec...

Full description

Saved in:
Bibliographic Details
Main Authors: Meqdad Saleh Ahmed, Zirak Faqe Ahmed Abdulrahman, Zanan Mohammed Ameen Taha
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2023/3139270
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849434918532153344
author Meqdad Saleh Ahmed
Zirak Faqe Ahmed Abdulrahman
Zanan Mohammed Ameen Taha
author_facet Meqdad Saleh Ahmed
Zirak Faqe Ahmed Abdulrahman
Zanan Mohammed Ameen Taha
author_sort Meqdad Saleh Ahmed
collection DOAJ
description Background. The secondary infection of multi and extensively drug-resistant “Acinetobacter baumannii” in severely ill COVID-19 individuals is usually associated with extended hospitalisation and a high mortality rate. The current study aimed to assess the exact incidence rate of A. baumannii coinfection in severely ill COVID-19 patients admitted to intensive care unit (ICUs), to identify the possible mechanism of A. baumannii transfer to COVID-19 patients and to find out their resistance rate against different antibiotics. Methods. Fifty severely ill “COVID-19” individuals on respiratory support were selected with samples being collected from the pharynx. In addition, another 60 samples were collected from the surrounding environment. Bacterial isolates were diagnosed by microbiological cultures and confirmed by “Vitek 2 system” and real-time PCR. The “Vitek 2 Compact system” was used to evaluate these isolates for antimicrobial susceptibility. The recovered isolates’ DNA fingerprints and genetic similarities were performed using ERIC-PCR. Results.Twenty-six samples were tested positive for A. baumannii (20 out of 50 samples taken from patients, 40%; 6 out of 60 swabs from a nosocomial setting, 10%). All A. baumannii strains isolated from the nosocomial sites were clonally related (have the same genetic lineage) to some strains isolated from patients. However, the majority of the patients’ strains were categorised as belonging to the same genetic lineage. Furthermore, “the multi and extensively drug” resistance patterns were seen in all isolates. In addition, total isolates showed resistance to the most commonly tested antibiotics, while none of them was found to be resistant to tigecycline. Conclusion. Secondary “A. baumannii” infection in severely ill “COVID-19” patients is a serious matter, especially when it has one spot of transmission in the ICU as well as when it is extensively drug-resistant, necessitating an immediate and tactical response to secure the issue.
format Article
id doaj-art-ddeee0a687f64ff7af9ebc389609654d
institution Kabale University
issn 1918-1493
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-ddeee0a687f64ff7af9ebc389609654d2025-08-20T03:26:29ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932023-01-01202310.1155/2023/3139270Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 PatientsMeqdad Saleh Ahmed0Zirak Faqe Ahmed Abdulrahman1Zanan Mohammed Ameen Taha2College of Veterinary Medicine Department of Pathology and MicrobiologyCollege of EducationCollege of Veterinary Medicine Department of Pathology and MicrobiologyBackground. The secondary infection of multi and extensively drug-resistant “Acinetobacter baumannii” in severely ill COVID-19 individuals is usually associated with extended hospitalisation and a high mortality rate. The current study aimed to assess the exact incidence rate of A. baumannii coinfection in severely ill COVID-19 patients admitted to intensive care unit (ICUs), to identify the possible mechanism of A. baumannii transfer to COVID-19 patients and to find out their resistance rate against different antibiotics. Methods. Fifty severely ill “COVID-19” individuals on respiratory support were selected with samples being collected from the pharynx. In addition, another 60 samples were collected from the surrounding environment. Bacterial isolates were diagnosed by microbiological cultures and confirmed by “Vitek 2 system” and real-time PCR. The “Vitek 2 Compact system” was used to evaluate these isolates for antimicrobial susceptibility. The recovered isolates’ DNA fingerprints and genetic similarities were performed using ERIC-PCR. Results.Twenty-six samples were tested positive for A. baumannii (20 out of 50 samples taken from patients, 40%; 6 out of 60 swabs from a nosocomial setting, 10%). All A. baumannii strains isolated from the nosocomial sites were clonally related (have the same genetic lineage) to some strains isolated from patients. However, the majority of the patients’ strains were categorised as belonging to the same genetic lineage. Furthermore, “the multi and extensively drug” resistance patterns were seen in all isolates. In addition, total isolates showed resistance to the most commonly tested antibiotics, while none of them was found to be resistant to tigecycline. Conclusion. Secondary “A. baumannii” infection in severely ill “COVID-19” patients is a serious matter, especially when it has one spot of transmission in the ICU as well as when it is extensively drug-resistant, necessitating an immediate and tactical response to secure the issue.http://dx.doi.org/10.1155/2023/3139270
spellingShingle Meqdad Saleh Ahmed
Zirak Faqe Ahmed Abdulrahman
Zanan Mohammed Ameen Taha
Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
Canadian Journal of Infectious Diseases and Medical Microbiology
title Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
title_full Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
title_fullStr Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
title_full_unstemmed Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
title_short Risk Factors of Clonally Related, Multi, and Extensively Drug-Resistant Acinetobacter baumannii in Severely Ill COVID-19 Patients
title_sort risk factors of clonally related multi and extensively drug resistant acinetobacter baumannii in severely ill covid 19 patients
url http://dx.doi.org/10.1155/2023/3139270
work_keys_str_mv AT meqdadsalehahmed riskfactorsofclonallyrelatedmultiandextensivelydrugresistantacinetobacterbaumanniiinseverelyillcovid19patients
AT zirakfaqeahmedabdulrahman riskfactorsofclonallyrelatedmultiandextensivelydrugresistantacinetobacterbaumanniiinseverelyillcovid19patients
AT zananmohammedameentaha riskfactorsofclonallyrelatedmultiandextensivelydrugresistantacinetobacterbaumanniiinseverelyillcovid19patients